Portfolio (Quarterly)
Guide ↗
Soleus Capital Management, L.P.
· CIK 0001802630| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 81 | TECX | TECTONIC THERAPEUTIC INC | Healthcare | 101,684.0 | $3.5M | 0.12% | -20K | -16.4% | $34.38 | +4.6% |
| 82 | AXGN | AXOGEN INC | Healthcare | 57,036.0 | $2.6M | 0.09% | -622K | -91.6% | $46.19 | +11.7% |
| 83 | MSLE | SATELLOS BIOSCIENCE INC | Healthcare | 314,359.0 | $2.4M | 0.08% | -100K | -24.1% | $7.78 | +20.4% |
| 84 | AVBP | ARRIVENT BIOPHARMA INC | Healthcare | 50,000.0 | $1.7M | 0.06% | NEW | — | $34.74 | -10.4% |
| 85 | CORT | CORCEPT THERAPEUTICS INC | Healthcare | 19,653.0 | $1.7M | 0.06% | -266K | -93.1% | $86.95 | +37.8% |
| 86 | — | SOLID BIOSCIENCES INC | — | 150,000.0 | $1.5M | 0.05% | NEW | — | $9.99 | — |
| 87 | VCYT | VERACYTE INC | Healthcare | 25,000.0 | $1.5M | 0.05% | -295K | -92.2% | $58.73 | -24.6% |
| 88 | CGEM | CULLINAN THERAPEUTICS INC | Healthcare | 50,000.0 | $910K | 0.03% | -360K | -87.8% | $18.21 | +25.5% |
| 89 | — | INSPIREMD INC | — | 1,045,708.0 | $732K | 0.03% | — | — | $0.70 | — |
| 90 | WGS | GENEDX HOLDINGS CORP | Healthcare | 10,000.0 | $686K | 0.02% | NEW | — | $68.65 | +31.5% |
| 91 | IOVA | IOVANCE BIOTHERAPEUTICS INC | Healthcare | 150,000.0 | $624K | 0.02% | -850K | -85.0% | $4.16 | +94.2% |
| 92 | LRMR | LARIMAR THERAPEUTICS INC | Healthcare | 188,102.0 | $574K | 0.02% | -879K | -82.4% | $3.05 | +36.7% |
| 93 | CGON | CG ONCOLOGY INC | Healthcare | 5,000.0 | $355K | 0.01% | -15K | -75.0% | $71.05 | +10.4% |
| 94 | QNRX | QUOIN PHARMACEUTICALS LTD | Healthcare | 72,730.0 | $352K | 0.01% | — | — | $4.84 | +7.0% |
| 95 | EQ | EQUILLIUM INC | Healthcare | 90,000.0 | $288K | 0.01% | NEW | — | $3.20 | -26.2% |
| 96 | NTRA | NATERA INC | Healthcare | 1,000.0 | $271K | 0.01% | -118K | -99.2% | $271.45 | +24.7% |
| 97 | NEO | NEOGENOMICS INC | Healthcare | 10,000.0 | $146K | 0.01% | -165K | -94.3% | $14.59 | +19.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%